Pre-clinical evaluation of second generation PIM inhibitors for the treatment of T-cell acute lymphoblastic leukemia and lymphomaRenate De Smedt, Pieter Van Vlierberghe, Julie Morscio et al.|Haematologica|2018Cited by 32